Diseases, Conditions, Syndromes

Major COVID-19 vaccine trial resumes in UK after safety review

Pharma giant AstraZeneca and Oxford University on Saturday said they had resumed a COVID-19 vaccine trial after getting the all-clear from British regulators, following a pause caused by a UK volunteer falling ill.

Diseases, Conditions, Syndromes

Brazil to produce Chinese coronavirus vaccine: officials

Brazilian officials on Thursday announced an agreement with China's Sinovac Biotech to produce its coronavirus vaccine in the state of Sao Paulo, where tests involving 9,000 volunteers are to begin next month.

Diseases, Conditions, Syndromes

FDA gives first Ebola vaccine for adults the green light

(HealthDay)—The first Ebola vaccine approved by the U.S. Food and Drug Administration is a single-dose injection called Ervebo. The vaccine from Merck & Co. is approved to protect against the Zaire ebolavirus in people ...

Vaccination

Covaxin approval requested in US for ages 2-18

US company Ocugen announced Friday that it had asked authorities for emergency use authorization for COVID-19 vaccine Covaxin, which was developed in India, for ages 2 to 18.

page 2 from 40